ClinicalTrials.Veeva

Menu

Evaluation of Pregnancy Associated Plasma Protein A (PAPPA) as a Biomarker in Breast Cancer.

A

Assiut University

Status

Not yet enrolling

Conditions

Breast Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT06174571
PAPPA & breast cancer

Details and patient eligibility

About

This work aims to:

  1. Evaluation of the role of pregnancy associated plasma protein A( PAPPA ) in diagnosis & early detection of breast cancer.
  2. Evaluation of the relationship between ( PAPPA ) levels and stages of breast cancer.

Enrollment

90 estimated patients

Sex

Female

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • female patients with breast cancer who were diagnosed by histopathological studies and did not receive any treatment.

Exclusion criteria

  • Patients who received chemotherapy or radiotherapy.
  • Patients with known other organ malignancy.

Trial design

90 participants in 2 patient groups

1
Description:
patients diagnosed with breast cancer at different stages of the disease.
2
Description:
apparently healthy females as a control group.

Trial contacts and locations

0

Loading...

Central trial contact

Aya Hasan Abdulhady

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems